Paper34769259
Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents.
Carlsen L and 1 other. Int J Mol Sci, 2021. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents. Papers, record 34769259. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34769259
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Apoptosis | Major topic |
| DNA Damage | Major topic |
| DNA, Neoplasm | Major topic |
| Neoplasms | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| DNA Repair | |
| Humans |
Source PubMed
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32303678 | The p53/MDM2/MDMX-targeted therapies-a clinical synopsis. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32303678 | PubMed |
| 2 | 14580351 | p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage. | Mol Cell | 2003 | https://conductscience.org/library/papers/14580351 | PubMed |
| 3 | 25806108 | New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy. | J Immunother Cancer | 2015 | https://conductscience.org/library/papers/25806108 | PubMed |
| 4 | 18779317 | p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines. | Mol Cell Biol | 2008 | https://conductscience.org/library/papers/18779317 | PubMed |
| 5 | 31365877 | Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas. | Cell Rep | 2019 | https://conductscience.org/library/papers/31365877 | PubMed |
| 6 | 29099489 | Deconstructing networks of p53-mediated tumor suppression in vivo. | Cell Death Differ | 2018 | https://conductscience.org/library/papers/29099489 | PubMed |
| 7 | 26732534 | Targeting Oncogenic Mutant p53 for Cancer Therapy. | Front Oncol | 2015 | https://conductscience.org/library/papers/26732534 | PubMed |
| 8 | 33932560 | Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. | Biochim Biophys Acta Rev Cancer | 2021 | https://conductscience.org/library/papers/33932560 | PubMed |
| 9 | 17334395 | p63 and p73 in human cancer: defining the network. | Oncogene | 2007 | https://conductscience.org/library/papers/17334395 | PubMed |
| 10 | 22673234 | The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells. | Cancer Res | 2012 | https://conductscience.org/library/papers/22673234 | PubMed |
| 11 | 28280037 | Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity. | Cancer Res | 2017 | https://conductscience.org/library/papers/28280037 | PubMed |
| 12 | 21764762 | Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2. | Cancer Res | 2011 | https://conductscience.org/library/papers/21764762 | PubMed |
| 13 | 10212189 | p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10212189 | PubMed |
| 14 | 31282934 | p53 modifications: exquisite decorations of the powerful guardian. | J Mol Cell Biol | 2019 | https://conductscience.org/library/papers/31282934 | PubMed |
| 15 | 21941086 | Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2. | Cell Cycle | 2011 | https://conductscience.org/library/papers/21941086 | PubMed |
| 16 | 30320184 | Immunogenic effects of chemotherapy-induced tumor cell death. | Genes Dis | 2018 | https://conductscience.org/library/papers/30320184 | PubMed |
| 17 | 23965983 | p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1. | Nat Commun | 2013 | https://conductscience.org/library/papers/23965983 | PubMed |
| 18 | 30450666 | Recent clinical trends in Toll-like receptor targeting therapeutics. | Med Res Rev | 2019 | https://conductscience.org/library/papers/30450666 | PubMed |
| 19 | 17251932 | Restoration of p53 function leads to tumour regression in vivo. | Nature | 2007 | https://conductscience.org/library/papers/17251932 | PubMed |
| 20 | 11875500 | Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound. | Nat Med | 2002 | https://conductscience.org/library/papers/11875500 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42598159 | Association between the expression of GSTP1 and mutant p53, poor chemotherapy response and metastasis in patients with osteosarcoma. | Oncol Lett | 2026 | https://conductscience.org/library/papers/42598159 | PubMed |
| 41985006 | PTP4A2 promotes leukemogenesis through inhibiting the p53 tumor suppressor signaling pathway in leukemia-initiating cells. | Blood Adv | 2026 | https://conductscience.org/library/papers/41985006 | PubMed |
| 39060302 | Functional evaluation of germline TP53 variants identified in Brazilian families at-risk for Li-Fraumeni syndrome. | Sci Rep | 2024 | https://conductscience.org/library/papers/39060302 | PubMed |
| 38366290 | Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38366290 | PubMed |
| 38311377 | Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy. | Cancer Commun (Lond) | 2024 | https://conductscience.org/library/papers/38311377 | PubMed |
| 38135693 | The dual activity of CaONPs as a cancer treatment substance and at the same time resistance to harmful microbes. | Sci Rep | 2023 | https://conductscience.org/library/papers/38135693 | PubMed |
| 38005258 | Ruthenium(II)-Arene Curcuminoid Complexes as Photosensitizer Agents for Antineoplastic and Antimicrobial Photodynamic Therapy: In Vitro and In Vivo Insights. | Molecules | 2023 | https://conductscience.org/library/papers/38005258 | PubMed |
| 37509605 | The Novel MDM4 Inhibitor CEP-1347 Activates the p53 Pathway and Blocks Malignant Meningioma Growth In Vitro and In Vivo. | Biomedicines | 2023 | https://conductscience.org/library/papers/37509605 | PubMed |
| 37407287 | Transcriptional pausing induced by ionizing radiation enables the acquisition of radioresistance in nasopharyngeal carcinoma. | J Mol Cell Biol | 2024 | https://conductscience.org/library/papers/37407287 | PubMed |
| 37108395 | Resistance to TOP-1 Inhibitors: Good Old Drugs Still Can Surprise Us. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108395 | PubMed |
| 37047251 | Plumbagin Exhibits Genotoxicity and Induces G2/M Cell Cycle Arrest via ROS-Mediated Oxidative Stress and Activation of ATM-p53 Signaling Pathway in Hepatocellular Cells. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047251 | PubMed |
| 36910143 | ROS production in response to high-power microwave pulses induces p53 activation and DNA damage in brain cells: Radiosensitivity and biological dosimetry evaluation. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/36910143 | PubMed |
| 36775894 | Diepoxybutane induces the p53-dependent transactivation of the CCL4 gene that mediates apoptosis in exposed human lymphoblasts. | J Biochem Mol Toxicol | 2023 | https://conductscience.org/library/papers/36775894 | PubMed |
| 36214609 | MYC and therapy resistance in cancer: risks and opportunities. | Mol Oncol | 2022 | https://conductscience.org/library/papers/36214609 | PubMed |
| 36090037 | Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/36090037 | PubMed |
| 35806255 | Targeted Modulation of Interferon Response-Related Genes with IFN-Alpha/Lambda Inhibition. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35806255 | PubMed |
| 35792674 | The Elephant Evolved p53 Isoforms that Escape MDM2-Mediated Repression and Cancer. | Mol Biol Evol | 2022 | https://conductscience.org/library/papers/35792674 | PubMed |
| 35634298 | Cytosolic p53 Inhibits Parkin-Mediated Mitophagy and Promotes Acute Liver Injury Induced by Heat Stroke. | Front Immunol | 2022 | https://conductscience.org/library/papers/35634298 | PubMed |
| 35312310 | Nitrogen Mustard Alkylates and Cross-Links p53 in Human Keratinocytes. | Chem Res Toxicol | 2022 | https://conductscience.org/library/papers/35312310 | PubMed |
| 35208631 | Ofeleein i mi Vlaptin-Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic. | Medicina (Kaunas) | 2022 | https://conductscience.org/library/papers/35208631 | PubMed |
Genes64
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34769259
GET https://conductscience.org/api/papers/v1/34769259/references?page=2